Real-World-Data–MehrwertfürForschungundmedizinischeVersorgung

Partex.AI Data unterstützt Pharmaunternehmen, CROs und Gesundheitsdienstleister dabei, Innovationen zu beschleunigen – mit hochwertigen Real-World-Data, intelligenten KI-Methoden und datengetriebenen Lösungen für jede Phase der klinischen Entwicklung

    Through global healthcare partnerships, we access high-quality Real-World Data, including registry and clinical study data, to advance data-driven medicine

    Hyperledger-based consent management ensures secure, compliant, and auditable patient data use

    Anonymize, structure, and transform real-world data into products and services for advanced analytics

    Transparent incentive model for data custodians and data owners

    Compliance with global privacy and data protection standards (GDPR, HIPAA, DPDP, FADP)

Exploring Real World Applications With Real World Data

Traditional control arm design is impractical for rare diseases and ethically challenging to implement for providing a comparison group

Virtual Patients for Clinical Trial Simulation

Generate virtual patients based on clinical data distribution

Solution:

Facilitates trial design with regard to patient population

Site selection & effective recruitment

Insights into various aspects of patient demographics, disease prevalence

Solution:

Identify sites with a suitable patient population

Biomarker Candidate Identification

Identify relevant biomarkers in patient data

Solution:

More precise disease diagnosis, prognosis, and treatment selection

Comparative Effectiveness Research

Compare the outcomes of drugs against competitors

Solution:

Support evidence-based decision-making by healthcare providers

Post-Marketing Surveillance

Provide safety monitoring and pharmacovigilance

Solution:

Support to detect and assess adverse events, monitor long-term safety, and evaluate the real-world effectiveness of their drugs

Health Economics & Market Access

Evaluate the cost-effectiveness & impact on healthcare utilization

Solution:

Support for market access negotiations and reimbursement decisions

Market Understanding and Commercial Strategy

Provide insights into patient behaviors, treatment patterns, and unmet medical needs in the market

Solution:

Support in refining commercialization strategies

Data Products for Machine Learning

Provide validated and labelled training datasets

Solution:

Support supervised learning models

Real-World Datasets

Clinical Data

Diagnosis, treatments, lab results, ECOG scores, adverse events, survival outcomes

Study and Registry Data

Offering insights into outcomes, patient profiles, and real-world effectiveness

Imaging Data

Radiology and pathology reports, DICOM images

Genomic Data

Somatic mutations, sequencing reports, relevant biomarkers

Treatment Pathways

Line of therapy, dosage, combinations, progression

Outcome Data

Progression-free survival (PFS), overall survival (OS), treatment response, patient-reported outcomes

Wir entdecken nicht nur Medikamente,

wir gestalten ihre Zukunft

Sprechen Sie mit uns, um Datenpartnerschaften oder den Einsatz von KI zur Neugestaltung Ihrer Wirkstoffpipeline zu erkunden

Kontaktieren Sie uns